Literature DB >> 8245793

The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer.

P De Camilli1, A Thomas, R Cofiell, F Folli, B Lichte, G Piccolo, H M Meinck, M Austoni, G Fassetta, G Bottazzo, D Bates, N Cartlidge, M Solimena, M W Kilimann.   

Abstract

Stiff-Man syndrome (SMS) is a rare disease of the central nervous system (CNS) characterized by progressive rigidity of the body musculature with superimposed painful spasms. An autoimmune origin of the disease has been proposed. In a caseload of more than 100 SMS patients, 60% were found positive for autoantibodies directed against the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). Few patients, all women affected by breast cancer, were negative for GAD autoantibodies but positive for autoantibodies directed against a 128-kD synaptic protein. We report here that this antigen is amphiphysin. GAD and amphiphysin are nonintrinsic membrane proteins that are concentrated in nerve terminals, where a pool of both proteins is associated with the cytoplasmic surface of synaptic vesicles. GAD and amphiphysin are the only two known targets of CNS autoimmunity with this distribution. This finding suggests a possible link between autoimmunity directed against cytoplasmic proteins associated with synaptic vesicles and SMS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245793      PMCID: PMC2191289          DOI: 10.1084/jem.178.6.2219

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  Co-secretion of multiple signal molecules from endocrine cells via distinct exocytotic pathways.

Authors:  P De Camilli
Journal:  Trends Pharmacol Sci       Date:  1991-12       Impact factor: 14.819

Review 2.  Pathways to regulated exocytosis in neurons.

Authors:  P De Camilli; R Jahn
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

Review 3.  A critical survey of stiff-man syndrome.

Authors:  E E Gordon; D M Januszko; L Kaufman
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

4.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

5.  Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.

Authors:  D J Hetzel; C R Stanhope; B P O'Neill; V A Lennon
Journal:  Mayo Clin Proc       Date:  1990-12       Impact factor: 7.616

6.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.

Authors:  M Solimena; F Folli; S Denis-Donini; G C Comi; G Pozza; P De Camilli; A M Vicari
Journal:  N Engl J Med       Date:  1988-04-21       Impact factor: 91.245

7.  Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

Authors:  F Folli; M Solimena; R Cofiell; M Austoni; G Tallini; G Fassetta; D Bates; N Cartlidge; G F Bottazzo; G Piccolo; P De Camilli
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

8.  GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion.

Authors:  A Reetz; M Solimena; M Matteoli; F Folli; K Takei; P De Camilli
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

9.  Amphiphysin, a novel protein associated with synaptic vesicles.

Authors:  B Lichte; R W Veh; H E Meyer; M W Kilimann
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

10.  Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.

Authors:  M H Butler; M Solimena; R Dirkx; A Hayday; P De Camilli
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  63 in total

1.  Stiff-man syndrome in childhood.

Authors:  V Markandeyulu; T P Joseph; T Solomon; J Jacob; S Kumar; C Gnanamuthu
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

Review 2.  Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes.

Authors:  Goran Rakocevic; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

Review 3.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

4.  Update on paraneoplastic neurologic disorders.

Authors:  Myrna R Rosenfeld; Josep Dalmau
Journal:  Oncologist       Date:  2010-05-17

Review 5.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

6.  Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation.

Authors:  Mark R Ambroso; Balachandra G Hegde; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

7.  Amphiphysin I but not dynamin I nor synaptojanin mRNA expression increased after repeated methamphetamine administration in the rat cerebrum and cerebellum.

Authors:  Mitsuko Hamamura; Jiro Okouchi; Hidetoshi Ozawa; Yoshihiko Kimuro; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J Neural Transm (Vienna)       Date:  2012-12-08       Impact factor: 3.575

Review 8.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  Paraneoplastic movement disorders.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

10.  Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.

Authors:  M Hummel; I Durinovic-Bello; E Bonifacio; V Lampasona; J Endl; S Fessele; F Then Bergh; C Trenkwalder; E Standl; A G Ziegler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.